arrow
M

Michel Bilello

University of Pennsylvania
H指数:37
被引数:9,337

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fast Submillimeter Whole-Brain T2*-Weighted Imaging Using 3D-EPI With CAIPIRINHA and Deep-Learning Denoising at 3T

基于CAIPIRINHA和深度学习去噪的3T下3D-EPI快速亚毫米全脑T<sub>2</sub>*加权成像

2026-09-150
PRE
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study

基于个性化机器学习指导的 Newly Diagnosed Glioblastoma 患者放射剂量递增:前瞻性试点研究

2026-05-130
OAAI
Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge

通过联合肿瘤分割 (FeTS) 挑战实现医疗AI算法的公平分散基准测试

2025-07-080
OAAI
AI-GUIDED PERSONALIZED PRECISION RADIATION THERAPY WITH TARGETED DOSE ESCALATION FOR NEWLY DIAGNOSED GLIOBLASTOMA: A MATCHED-CONTROL STUDY
2024-11-110
PRE
Multicenter Automated Central Vein Sign Detection Performs as Well as Manual Assessment for the Diagnosis of Multiple Sclerosis

多中心自动化中心静脉征检测在多发性硬化症诊断中的表现与手动评估相当

2024-09-271
PRE
Federated learning enables big data for rare cancer boundary detection (vol 13, 7346, 2022)
2023-01-263
OAAI
Federated learning enables big data for rare cancer boundary detection

联邦学习支持罕见癌症边界检测的大数据

2022-12-05110
OAAI
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics

宾夕法尼亚大学胶质母细胞瘤 (upenn-gbm) 队列: 先进的MRI,临床,基因组学和放射组学

2022-07-290
OAAI
The Medical Segmentation Decathlon

医学细分迪卡侬

2022-07-15371
OAAI
Multi-institutional noninvasive in vivo characterization of IDH, 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk)
2021-01-2318
OAAI
Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma
2020-11-0133
OAAI
AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium
2020-03-1037
OA
Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma
CANCER
IF5.1
2020-03-0474
OAAI